GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (OTCPK:GLABF) » Definitions » Total Receivables

GLABF (Gemina Laboratories) Total Receivables : $0.01 Mil (As of Oct. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gemina Laboratories Total Receivables?

Gemina Laboratories's Total Receivables for the quarter that ended in Oct. 2024 was $0.01 Mil.


Gemina Laboratories Total Receivables Historical Data

The historical data trend for Gemina Laboratories's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Total Receivables Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Total Receivables
- 0.15 0.29 0.03

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.03 0.03 0.02 0.01

Gemina Laboratories Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Gemina Laboratories Total Receivables Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Gemina Laboratories Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.